ENDLOS-TURBO PUT - STRATEC BIOMEDICAL Share Price

Certificat

DE000DJ5CV30

Market Closed - Deutsche Boerse AG 20:35:17 31/05/2024 BST
0.29 EUR -36.96% Intraday chart for ENDLOS-TURBO PUT - STRATEC BIOMEDICAL
Current month-63.75%
1 month-63.75%
Date Price Change
31/05/24 0.29 -36.96%
30/05/24 0.46 -2.13%
29/05/24 0.47 +9.30%
28/05/24 0.43 -25.86%
24/05/24 0.58 -3.33%

Delayed Quote Deutsche Boerse AG

Last update May 31, 2024 at 08:35 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying STRATEC SE
Issuer DZ BANK
WKN DJ5CV3
ISINDE000DJ5CV30
Date issued 05/09/2023
Strike 50.99
Maturity Unlimited
Parity 10 : 1
Emission price 0.247
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.59
Lowest since issue 0.23

Company Profile

Stratec SE is a Germany-based company engaged in the development and manufacture of fully automated systems based on its own patented technologies for its partners in the fields of in-vitro diagnostics and life sciences in Germany and internationally. Its business activities are divided into three segments: Instrumentation, which designs and manufactures fully automated analyzer systems for its clinical diagnostics and biotechnology customers; Diatron, which offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications, and Consumables, which develops and sells scientific materials, such as nucleic acid purification and designs and produces smart consumables in the fields of diagnostics, life sciences, and medical technology. In addition, the Company develops workflow software for networking various analyzer systems, as well as develops and sells scientific materials and technologies.
Sector
-
More about the company

Ratings for Stratec SE

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Stratec SE

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
47.65 EUR
Average target price
42.33 EUR
Spread / Average Target
-11.16%
Consensus